Search clinical trials for: PREVENA

Total 289 results

Pfizer

Completed

Prevenar13 Drug Use Investigation - Adults Aged 65 Years or Older-

Adult Not Younger Than 65 Years

Japan
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

Childhood Cancer | Multiple Diseases

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma

Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Recurrent T-Cell Non-Hodgkin Lymphoma | Aggressive Non-Hodgkin... and other conditions

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Tolerability of V114 and Prevnar 13™ in Healthy Infants (V114-031/PNEU-LINK)

Pneumococcal Infections

United States, Australia, Canada, Finland, Germany, Israel, Malaysia, Peru, Taiwan, Thailand
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033)

Pneumococcal Infections

Japan
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) (PNEU-PED)

Pneumococcal Infections | Pneumococcal Vaccines

United States, Puerto Rico, Thailand, Turkey
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025) (PNEU-PED-EU-1)

Pneumococcal Infections

Australia, Belgium, Czechia, Estonia, Germany, Greece, Poland, Russian Federation, Spain
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)

Pneumococcal Infections

United States, Australia, Belgium, Brazil, Canada, Colombia, France, Germany, Mexico, Sweden
Centre Hospitalier Universitaire de Saint Etienne
Pfizer

Terminated

Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD (PneumoMICI)

Bowel Diseases, Inflammatory | Infections, Pneumococcal

France
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED) (PNEU-WAY PED)

Pneumococcal Infections

South Africa, Thailand, Ukraine
Indiana University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Terminated

Preventing Adverse Incisional Outcomes at Cesarean Multicenter Trial (Prevena-C)

Cesarean Section | Surgical Wound Infection

United States
Sheffield Teaching Hospitals NHS Foundation Trust
3M

Completed

Prevena Incision Management (Prevena)

Cardiac Event | Complication of Coronary Artery Bypass Graft | Coronary Bypass Graft Stenosis | Arrest; Cardiac, Complicating Surgery

United Kingdom
Pfizer

Completed

Impact of Prevnar 13 on Ear Infections in Children

Acute Otitis Media | Mastoiditis

United States
University of Maryland, Baltimore

Withdrawn

Incisional Negative Pressure Dressing on Clean Closed Groin Incisions

Complication of Surgical Procedure

United States
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026) (PNEU-PED-EU-2)

Pneumococcal Infections

Denmark, Finland, Italy, Norway, Sweden
Western University, Canada
Lawson Health Research Institute

Withdrawn

NPWT for Abdominal Incisions in DIEP Reconstructions: A RCT (NPWTinDIEP)

Breast Cancer | Surgical Site Infection | Wound Dehiscence

Canada
Columbia University
Kinetic Concepts, Inc.

Completed

Closed Incision Negative Pressure Therapy vs Standard of Care (Prevena)

Wound Complication

United States, Canada
3M
KCI Europe Holding B.V.

Terminated

The Use of PrevenaTM on Clean Closed Sternal Midline Incisions in Subjects at High Risk for Surgical Site Occurrences.

Wound Infection | Surgical Site Occurences After Sternotomy

Germany, Netherlands, Austria
Region Örebro County

Completed

Immune Response After Pneumococcal Vaccination in Patient With Chronic Lymphocytic Leukemia

Vaccine Response | CLL

Sweden
Region Skane

Completed

Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease (IPS-BOOSTER)

Rheumatoid Arthritis | Systemic Vasculitis | Spondyloarthritis | Systemic Lupus | Sjögren Syndrome
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)

Pneumococcal Infections

United States, Puerto Rico, Thailand, Turkey
Guy's and St Thomas' NHS Foundation Trust
National Institute for Health Research, United Kingdom

Active, not recruiting

Pneumococcal Vaccination to Accelerate Immune Recovery in Sepsis Survivors (VACIRiSS)

Sepsis

United Kingdom
Duke University
Kinetic Concepts, Inc.

Completed

Negative Pressure Wound Therapy to Reduce Surgical Site Infection

Patients Undergoing Hepatopancreatobiliary Surgery

United States
University of Illinois at Chicago
University of Maryland; University of Iowa; Emory University; Centers for Disease... and other collaborators

Completed

SUpPress SSI - Single Use Negative Pressure Wound Therapy (NPWT) to Reduce Surgical Site Infections (SUpPressSSI)

Obesity | Diabetes | Cesarean Section Complications | Surgical Site Infection

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)

Multiple Myeloma

United States
The Cleveland Clinic

Completed

Prevena™ Incisional Negative Pressure Wound Therapy in Re-operative Colorectal Surgery

Surgical Site Infection

United States
Assistance Publique - Hôpitaux de Paris
Recherche Clinique Paris Descartes Necker Cochin Sainte Anne; EUCLID Clinical... and other collaborators

Active, not recruiting

Revaccination With PPS23 Boosted or Not by PCV13 in Splenectomised Patients. (SPLENEVAC-2)

Splenectomised Patients

France
Murdoch Childrens Research Institute
National Health and Medical Research Council, Australia; GlaxoSmithKline; Bill... and other collaborators

Completed

Trial of Pneumococcal Vaccine Schedules in Ho Chi Minh City, Vietnam

Pneumococcal Vaccines

Vietnam
Assistance Publique - Hôpitaux de Paris

Completed

Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells Disease (DREVAC)

Sickle Cells Disease | Invasive Pneumococcal Infections

France
Sanofi

Completed

Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.

Pneumoccocal Immunisation

United States
3M

Terminated

The Management of Closed Surgical Incisions Resulting From Incisional Hernia Repair and/or Functional Panniculectomy Using the Prevena™ Customizable™ Dressing

Abdominoplasty | Herniorrhaphy

United States
3M

Terminated

The Use of the Prevena Incision Management System (PIMS) on Closed Incisions in Renal Transplant Subjects (PIMS)

Surgical Site Reaction

United States
3M

Completed

The Use of the Prevena™ Incision Management System on Post-Surgical Cesarean Section Incisions

Surgical Wound Infection | Surgical Site Infection | Post-operative Complications

United States
3M

Completed

Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee Arthroplasty (PROMISES)

Pathologic Processes | Wounds and Injuries | Postoperative Complications | Surgical Wound | Infection | Musculoskeletal Disease | Prosthesis-Related Infections | Joint Disease | Revision Total Knee Arthroplasty

United States
3M

Withdrawn

Prevena™ Incision Management System Over Primarily Closed Hip and Knee Incisions in Patients Immediately Post Total Hip and Knee Arthroplasty (Prevena2009-45)

Total Knee Arthroplasty | Total Hip Arthroplasty | Linear or Emi-linear Incisions
Assistance Publique - Hôpitaux de Paris
Recherche Clinique Paris Descartes Necker Cochin Sainte Anne; EUCLID Clinical... and other collaborators

Completed

Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy (PNEUMOVAS)

Invasive Pneumococcal Infection

France
Affinivax, Inc.

Completed

A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator

Healthy Volunteers | Pneumococcal Disease

United States
University of Aarhus
Randers Regional Hospital

Terminated

Randomized Trial Comparing Prevena and ActiV.A.C. System to Convetional Care After Bascom's Cleft Lift Surgery

Pilonidal Disease

Denmark
University of Aarhus
Innovation Fund Denmark

Completed

Acute Studies on the Glycemic Index After Intake of Different Sorts of Barley in Subjects With Type 2 Diabetes

Type 2 Diabetes

Denmark
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018) (PNEU-WAY)

Pneumococcal Infections

United States, France, Peru, South Africa, Thailand
PATH
University College, London; FHI 360; Medical Research Council Unit, The Gambia; Serum Institute of India Pvt. Ltd...

Completed

Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants

Pneumonia, Pneumococcal

Gambia
Sanofi Pasteur, a Sanofi Company

Completed

A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers

Meningitis | Meningococcal Infection

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers

Dengue | Dengue Hemorrhagic Fever

Mexico
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

Herpes Zoster

United States, Germany, Estonia, Canada
University Hospital, Montpellier
Bristol-Myers Squibb

Completed

Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients (VACINA)

Rheumatoid Arthritis

France, Monaco
The Jackson Laboratory
University of Alabama at Birmingham; UConn Health

Completed

Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines

Pneumonia | Aging

United States
Pfizer

Terminated

Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants

Pneumococcal Infections

United States
Merck Sharp & Dohme LLC

Completed

Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13™ and Pneumovax™ 23 in Healthy Participants 50 Years of Age and Older (V110-029)

Pneumococcal Infections
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH) (PNEU-PATH)

Pneumococcal Infections

United States, Korea, Republic of, Spain, Taiwan
EuBiologics Co.,Ltd

Completed

Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults

Pneumococcal Disease

Korea, Republic of

Search clinical trials for: PREVENA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations